 Harmony Biosciences Holdings, Inc. NASDAQ:HRMY Q2 2022 Earnings Conference Call August 2, 2022 8:30 AM ET Company Participants Luis Sanay - Head, IR John Jacobs - President and CEO Jeffrey Dierks - Chief Commercial Officer Jeffrey Dayno - Chief Medical Officer Sandip Kapadia - CFO Conference Call Participants Chris Howerton - Jefferies Danielle Brill - Raymond James Charles Duncan - Cantor Fitzgerald Graig Suvannavejh - Goldman Sachs Corinne Jenkins - Goldman Sachs David Amsellem - Piper Sandler Francois Brisebois - Oppenheimer Operator Good morning, my name is Katie and Ill be your conference operator today. At this time, I would like to welcome everyone to the Harmony Biosciences Second Quarter 2022 Financial Update Conference Call. 